No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABBV240712C165000
- 5.50
- +0.58+11.79%
15min DelayClose Jul 12 16:00 ET
6.20High5.08Low
5.71Open4.92Pre Close46 Volume220 Open Interest165.00Strike Price26.37KTurnover0.00%IV0.13%PremiumJul 12, 2024Expiry Date5.28Intrinsic Value100Multiplier-1DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma36.42Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Morgan Stanley Sees $180B Patent Cliff, $380B Deal Capacity Fueling Biopharma M&A
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
AbbVie Earnings Preview: What to Expect
Express News | AbbVie Submits Applications To FDA And EMA For New Indication Of Upadacitinib (RINVOQ) For Treatment Of Giant Cell Arteritis; Supported By Phase 3 SELECT-GCA Study Showing Sustained Remission And Consistent Safety Profile
Express News | Abbvie Submits Regulatory Applications to FDA and EMA for Upadacitinib (Rinvoq®) in Giant Cell Arteritis
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and More
Comments
$Genmab(GMAB.US$ $AbbVie(ABBV.US$
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
EPKINLY (Epcoritamab) Now Approved for Patients w/ Follicular Lymphoma (FL)
» Positive results in Ph1/2 EPCORE® NHL-1 study for R/R FL
» Offers off-the-shelf T-cell therapy
» First-of-its-kind antibody for both R/R FL & DLBCL after prior treatments (2+ lines)
3
$Chevron(CVX.US$
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
One of the U.S.’s largest energy corporations, Chevron Corporation (NYSE:CVX) specializes in oil, gas and renewable fuels. The company has upstream and downstream operations focused on the oil and gas industry. Oil companies are an interesting pick since the best ones are known for paying dividends, even in bad times.
Chevron has a 37-year history of increasing dividends and has consistently paid them since ...
33
3
From YouTube
6
Interesting both for the (1) shift in the macro-trend to M&A (vs. Licensing) and (2) change in top spenders
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
$Merck & Co(MRK.US$ $Bristol-Myers Squibb(BMY.US$ $Johnson & Johnson(JNJ.US$ $Pfizer(PFE.US$ $Novo-Nordisk A/S(NVO.US$ $AbbVie(ABBV.US$
10
1
Read more